Search Back New search Go to resultsDiseaseMain groupSolid TumorsProtocol groupHead and Neck OncologyDiseaseAdenoid Cystic CarcinomaSubgroupICD10C44.-MeSHCarcinoma, Adenoid CysticSequenceChemotherapyChemo-substanceAxitinibChemo-substanceAxitinibChemo-substanceAxitinibChemo-substanceAxitinibNo. Substances1 RadiotherapySupportive therapySupportive substanceSupportive substanceSupportive substanceSupportive substanceNo. SubstancesProtocol classificationTherapy classificationalternativeIntensityStandard doseTherapy indicationseveral possibleTherapy phaseTherapy intentionpalliativeRisksConstipationDiarrheaEmetogenicity (ASCO)Hand-Foot SyndromeHeadacheHypertensionIncrease AminotransferasesMucositisProteinuriaQTc Time ExtensionRash only studiesPublicationAuthorKang EJDiseaseAdenoid-zystisches Karzinom, rezidiviert, inoperabel oder metastasiert, ECOG 0-1OriginKorea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of KoreaProtocols in Revision 1 protocol foundProtocols under revision. (PID2355 V1.0)
